![Anke Friedetzky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anke Friedetzky
Keine laufenden Positionen mehr
Profil
Anke Friedetzky worked as a Director of European Scientific Affairs at Kuur Therapeutics Ltd., a Member of Clinical Marketing Group at Miltenyi Biotec, Inc., and a Senior Medical Scientific Manager at Cephalon Ltd.
She received an undergraduate and doctorate degree from Philipps University of Marburg.
Ehemalige bekannte Positionen von Anke Friedetzky
Unternehmen | Position | Ende |
---|---|---|
Cephalon Ltd.
![]() Cephalon Ltd. Medical DistributorsDistribution Services Cephalon Ltd. distributes and markets pharmaceutical products. The company was founded on September 3, 2003 and was headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Miltenyi Biotec, Inc.
![]() Miltenyi Biotec, Inc. BiotechnologyHealth Technology Miltenyi Biotec, Inc. provides equipment and related services for biomedical research. The company was founded on April 2, 1992 and is headquartered in Auburn, CA. | Corporate Officer/Principal | - |
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anke Friedetzky
Philipps University of Marburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Kuur Therapeutics Ltd.
![]() Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Cephalon Ltd.
![]() Cephalon Ltd. Medical DistributorsDistribution Services Cephalon Ltd. distributes and markets pharmaceutical products. The company was founded on September 3, 2003 and was headquartered in London, the United Kingdom. | Distribution Services |
Miltenyi Biotec, Inc.
![]() Miltenyi Biotec, Inc. BiotechnologyHealth Technology Miltenyi Biotec, Inc. provides equipment and related services for biomedical research. The company was founded on April 2, 1992 and is headquartered in Auburn, CA. | Health Technology |